Acute Otitis Media (Child)

1. Clinical Overview

Summary

Acute Otitis Media (AOM) is an acute bacterial or viral infection of the middle ear, representing one of the most common childhood infections and the leading cause of antibiotic prescriptions in children. Approximately 80% of children experience at least one episode by age 3 years, with peak incidence between 6-18 months of age. [1,2] The condition typically follows a viral upper respiratory tract infection (URTI) that causes Eustachian tube dysfunction, leading to negative middle ear pressure, accumulation of middle ear effusion, and subsequent secondary bacterial colonization or infection. [3]

The predominant bacterial pathogens include Streptococcus pneumoniae (25-50%, declining with pneumococcal conjugate vaccine [PCV] use), nontypeable Haemophilus influenzae (NTHi, 15-30%), and Moraxella catarrhalis (10-20%). [1,4] Viral pathogens, particularly respiratory syncytial virus (RSV), rhinovirus, influenza, and adenovirus, frequently initiate the disease process and may be detected alone or in combination with bacteria. [3]

Children present with sudden-onset ear pain (otalgia), fever, irritability, and often a preceding URTI. The hallmark diagnostic finding on otoscopy is a bulging, erythematous, opacified tympanic membrane with reduced or absent mobility on pneumatic otoscopy—the most specific clinical sign. [5,6,21] A bulging tympanic membrane has a positive likelihood ratio of 51 for diagnosing AOM, making it the single most important diagnostic finding. [6]

Management follows an evidence-based, judicious approach balancing the benefits of antibiotic therapy against antimicrobial stewardship principles. Most cases (60-80%) are self-limiting and resolve spontaneously within 2-3 days without antibiotics. [7,8,22] Current guidelines recommend a watchful waiting strategy (observation with symptomatic treatment and delayed antibiotic prescription) for uncomplicated AOM in children ≥2 years with unilateral, mild disease. [9,24] Immediate antibiotic therapy is indicated for children less than 2 years with bilateral AOM, those with otorrhea (perforated tympanic membrane), severe symptoms, or systemic unwellness. [9,22]

Amoxicillin remains the first-line antibiotic, with dosing of 80-90 mg/kg/day divided three times daily in areas with high rates of pneumococcal resistance, or standard dosing of 40-50 mg/kg/day in low-resistance settings. [10,11] Treatment duration is typically 5 days in children ≥2 years and 10 days in children less than 2 years or those with severe disease. [9]

Complications, though rare in the antibiotic era, include tympanic membrane perforation (common and usually self-healing), acute mastoiditis (1-4 per 100,000 children, increasing in recent years), hearing loss (usually temporary conductive loss), recurrent AOM, chronic suppurative otitis media, and very rarely intracranial complications (meningitis, brain abscess). [12,13,34] Mastoiditis incidence has shown concerning increases during and after the COVID-19 pandemic, possibly related to reduced antibiotic use and delayed presentations. [13,34]

Clinical Pearls

"Bulging TM is Key": A bulging tympanic membrane is the hallmark finding (LR+ 51). This single finding has greater diagnostic accuracy than erythema, cloudiness, or even the presence of effusion alone. [6]

"Crying ≠ Red TM": Crying causes physiologic erythema of the tympanic membrane. Diagnosis requires the presence of middle ear effusion (bulging, limited mobility, air-fluid level, or otorrhea) plus signs of acute inflammation (distinct otalgia, marked erythema). [5]

"Most Resolve Without Antibiotics": Meta-analyses show 60-80% of AOM cases resolve spontaneously. Antibiotics reduce pain at 2-7 days with a number needed to treat (NNT) of 7-8. [7,8]

"Safety-Net is Essential": Watchful waiting requires robust safety-netting: advise parents to return if symptoms worsen, fail to improve within 48-72 hours, the child becomes systemically unwell, or new symptoms develop (rash, neck stiffness, facial droop). [9]

"High-Dose Amoxicillin in Resistance Areas": In regions with pneumococcal resistance rates > 10%, high-dose amoxicillin (80-90 mg/kg/day) achieves better middle ear fluid concentrations and improved outcomes. [10,11]

"Mastoiditis: The Key Red Flag": Acute mastoiditis presents with postauricular erythema, swelling, tenderness, and lateral/downward displacement of the auricle. It represents a surgical emergency requiring urgent ENT referral. [12,13]

"Perforation Often Relieves Pain": Spontaneous tympanic membrane perforation typically results in purulent otorrhea and rapid pain relief. Most perforations (> 90%) heal spontaneously within 2-4 weeks. [14]

---

2. Epidemiology

Demographics

Risk Factors

Patient-Related Factors

Environmental and Behavioral Factors

Protective Factors

Microbiology

Bacterial Pathogens (Pre-PCV vs PCV Era)

Viral Pathogens

Note: Viral-bacterial co-infection occurs in 50-70% of AOM cases. Viruses damage respiratory epithelium and upregulate bacterial adhesion receptors. [3]

Impact of Pneumococcal Conjugate Vaccine (PCV)

PCV introduction (PCV7 in 2000, PCV13 in 2010) significantly altered AOM epidemiology:

• Overall AOM incidence: Reduced by 15-20% in vaccinated populations. [17,27]
• Pneumococcal AOM: Reduced by 40-50% for vaccine serotypes. [17,27]
• Serotype replacement: Non-vaccine serotypes (particularly serotype 3 with PCV13, serotype 19A with PCV7) and NTHi have increased proportionally. [17,28,29]
• Complicated AOM: Reduced mastoiditis rates initially, but recent increases noted post-pandemic. [13,17,34]
• Antibiotic resistance: Overall pneumococcal resistance has decreased as vaccine serotypes had higher resistance rates. [17,29,30]

---

3. Pathophysiology

Anatomical Basis: Eustachian Tube in Children

The Eustachian tube connects the middle ear cavity to the nasopharynx and serves three critical functions:

1. Ventilation of the middle ear (pressure equalization)
2. Drainage of middle ear secretions
3. Protection from nasopharyngeal secretions and pathogens

Developmental differences in children predispose to AOM: [3]

These factors normalize by age 7-8 years, explaining the dramatic reduction in AOM incidence after early childhood.

Sequential Pathophysiological Stages

Stage 1: Viral Upper Respiratory Tract Infection (URTI)

Initiating event in > 80% of AOM cases. [3]

• Nasopharyngeal inflammation: Viral infection causes mucosal edema and increased mucus production.
• Eustachian tube edema: Inflammation extends to Eustachian tube ostia.
• Impaired ciliary function: Viral cytopathic effects damage respiratory epithelium and cilia.
• Increased bacterial adhesion: Viral infection upregulates receptors for bacterial adhesion (ICAM-1 for NTHi, PAF receptor for S. pneumoniae). [3]
• Immune modulation: Viral infection can suppress local antibacterial immunity.

Stage 2: Eustachian Tube Dysfunction

Functional obstruction occurs due to:

• Mucosal edema (from viral inflammation)
• Increased mucus (viscous secretions)
• Adenoid hypertrophy (mechanical obstruction)
• Negative nasopharyngeal pressure (from sniffing/sneezing)
• Supine position (reduces gravitational drainage)

Result: Blocked middle ear ventilation and drainage. [3]

Stage 3: Middle Ear Pressure Changes

Negative middle ear pressure develops through: [3]

1. Gas absorption: Oxygen and other gases absorbed from middle ear cavity into bloodstream via mucosa.
2. No replenishment: Blocked Eustachian tube prevents air entry.
3. Progressive vacuum: Pressure falls to -100 to -400 mm H₂O.

Clinical correlate: Type B tympanogram (flat); retracted tympanic membrane on otoscopy.

Stage 4: Middle Ear Effusion (Otitis Media with Effusion)

Negative pressure causes:

• Transudation of fluid from middle ear mucosa
• Mucus production by middle ear goblet cells (induced by negative pressure and inflammation)
• Vascular engorgement of middle ear mucosa

Effusion characteristics:

• Initially serous (thin, clear/yellow)
• Becomes mucoid (thick, glue-like) over days-weeks

Clinical correlate: "Glue ear" (OME) if no infection occurs. This stage is pre-suppurative and may or may not progress to bacterial AOM. [3]

Stage 5: Bacterial Colonization and Infection

Bacterial entry into middle ear via: [3,4]

1. Aspiration/reflux of nasopharyngeal contents during sniffing, crying, feeding (especially supine bottle feeding)
2. Direct Eustachian tube spread from nasopharyngeal colonization
3. Impaired clearance due to mucociliary dysfunction

Bacterial proliferation in middle ear effusion:

• Ideal growth medium: Warm, protein-rich fluid; reduced oxygen (favors some pathogens)
• Impaired immunity: Reduced antibody and complement in effusion initially
• Biofilm formation: Bacteria form biofilms on middle ear mucosa (particularly NTHi and S. pneumoniae), increasing antibiotic resistance and recurrence risk. [4]

Host inflammatory response:

• Neutrophil influx: Polymorphonuclear leukocytes recruited
• Cytokine release: IL-1β, IL-8, TNF-α cause further inflammation
• Pus formation: Effusion becomes purulent (cloudy, thick, yellow-green)

Clinical correlate: Acute suppurative otitis media; bulging, opaque tympanic membrane. [5,6]

Stage 6: Potential Outcomes

A. Spontaneous Resolution (60-80%) [7,8]

• Antibiotic-independent: Innate and adaptive immune responses clear infection
• Eustachian tube opens: Drainage and ventilation resume
• Effusion clears: May take days to weeks
• TM normalizes: Erythema resolves; mobility returns

B. Tympanic Membrane Perforation (5-15%) [14]

• Pressure rupture: Accumulating pus exceeds TM tensile strength
• Pars flaccida or tensa: Usually small perforation (1-3 mm)
• Otorrhea: Purulent discharge in external canal
• Pain relief: Pressure release provides rapid symptom improvement
• Spontaneous healing: > 90% heal within 2-4 weeks without intervention [14]

C. Persistence → Chronic OME (30-40%) [2]

• Effusion persists: Beyond 3 months despite resolution of acute symptoms
• Hearing impairment: Conductive hearing loss (20-40 dB)
• Speech/language concerns: If bilateral and prolonged (> 3 months)

D. Complications (Rare, less than 1-5%) [12,13]

See Complications section for detailed pathophysiology.

Molecular and Cellular Mechanisms

Bacterial Virulence Factors

Streptococcus pneumoniae: [4]

• Polysaccharide capsule: Antiphagocytic (> 90 serotypes)
• Pneumolysin: Cytotoxin causing ciliary damage and epithelial injury
• Autolysin: Releases bacterial components triggering inflammation
• Adhesins: PspA, PsaA for epithelial attachment

Nontypeable Haemophilus influenzae (NTHi): [4]

• Pili: Mediate adhesion to respiratory epithelium
• Lipooligosaccharide (LOS): Endotoxin triggering inflammation
• IgA protease: Cleaves secretory IgA (immune evasion)
• Biofilm formation: Extracellular matrix providing antibiotic protection

Moraxella catarrhalis: [4]

• UspA proteins: Adhesion and complement resistance
• Beta-lactamase: Antibiotic resistance (> 90% of strains)
• LOS: Pro-inflammatory

Host Immune Response

Innate immunity:

• Mucociliary clearance: Physical removal of pathogens
• Antimicrobial peptides: Defensins, lactoferrin in middle ear
• Complement activation: Opsonization and bacterial lysis
• Neutrophil recruitment: Phagocytosis and killing

Adaptive immunity:

• Antibody production: IgG, IgA against capsular and protein antigens
• T-cell responses: Th1 and Th17 responses
• Immunological memory: Reduces severity of subsequent episodes

Age-related immunological factors:

• Immature adaptive immunity: Peak AOM incidence coincides with physiological antibody nadir (6-12 months)
• Reduced pneumococcal antibodies: Before full vaccination and natural exposure
• Maternal antibody waning: By 6 months

---

4. Clinical Presentation

Symptoms

Primary Symptoms

Associated Symptoms

Red Flag Symptoms (Require Urgent Assessment)

Examination Findings

Otoscopic Findings (Tympanic Membrane)

Normal TM Landmarks (for comparison):

• Color: Pearly gray, translucent
• Light reflex: Cone of light anteroinferiorly
• Landmarks visible: Malleus handle, short process of malleus, pars tensa and flaccida, annulus
• Position: Neutral (not retracted or bulging)
• Mobility: Brisk movement with pneumatic otoscopy

AOM-Specific Findings (in order of diagnostic importance): [5,6]

Perforation Findings:

• Visible perforation: Hole in TM (pars tensa usually), often small (1-3 mm)
• Purulent otorrhea: Yellow/green discharge in canal and on TM
• Pulsatile discharge: Pus visibly pumping through perforation with heartbeat (in active infection)

Grading AOM Severity (based on otoscopic findings):

Examination Beyond the Ear

Special Examination Techniques

Pneumatic Otoscopy (Gold Standard): [6]

• Technique: Seal external canal with largest speculum; apply gentle positive and negative pressure using pneumatic bulb
• Normal: TM moves briskly inward and outward
• AOM: TM immobile or minimally mobile (effusion prevents movement)
• Sensitivity: 94% (when performed correctly)
• Specificity: 80%
• Limitation: Requires practice; often not performed in primary care

Tympanometry:

• Type A (normal): Sharp peak at 0 daPa (normal pressure, normal compliance)
• Type B (flat): No peak, low compliance (effusion present) — diagnostic of middle ear effusion
• Type C: Peak at negative pressure (Eustachian tube dysfunction without effusion)
• Role: Confirms effusion but doesn't differentiate AOM from OME; rarely used in acute care

Differential Diagnosis

---

5. Diagnosis

Diagnostic Criteria

American Academy of Pediatrics (AAP) 2013 Diagnostic Criteria [5]

AOM diagnosis requires ALL of the following:

1. Acute onset (symptoms less than 48 hours)

2. Presence of middle ear effusion (at least one):

• Bulging of TM
• Limited or absent TM mobility
• Air-fluid level behind TM
• Otorrhea (not due to otitis externa)

3. Signs/symptoms of middle ear inflammation (at least one):

• Distinct otalgia (discomfort clearly referable to ear, interfering with sleep/activity)
• Marked TM erythema (distinct, not diffuse)

Diagnostic Certainty Levels:

Note: Erythema alone or effusion alone does NOT equal AOM. Both inflammation AND effusion must be present.

Clinical Diagnosis

History (essential elements):

• Acute onset of symptoms (less than 48 hours)
• Ear pain (verbal child) or behavioral changes (tugging, irritability in infants)
• Fever (present in 50-70%)
• Preceding URTI symptoms (70-90%)
• Hearing difficulty (may be reported)
• Sleep disturbance

Examination (essential):

• Otoscopy (both ears, even if unilateral symptoms):
  • Assess TM color, position, translucency, landmarks
  • Pneumatic otoscopy (if available) for mobility
  • Document bulging, erythema, perforation, otorrhea

Diagnostic Accuracy: [6]

Combining history and otoscopy:

• Sensitivity: 85-95% (for experienced examiners)
• Specificity: 70-85%
• Positive Predictive Value: 80-90% (primary care prevalence)

Common Diagnostic Errors:

1. Overcalling AOM: Diagnosing based on erythema alone (child crying, fever causes physiologic erythema)
2. Undercalling AOM: Missing mild bulging; inadequate otoscopy (wax, uncooperative child)
3. Confusing OME with AOM: Effusion present but no acute inflammation
4. Missing bilateral disease: Examining only symptomatic ear

Investigations

AOM is a clinical diagnosis. Investigations are NOT routinely required.

Tympanocentesis Technique (specialist procedure):

• Indications: Severe otalgia unresponsive to treatment, immunocompromised, neonatal AOM, suspected resistant pathogen
• Technique: Myringotomy (small incision in anteroinferior TM quadrant) and aspiration under microscopy
• Benefits: Pain relief (pressure release), pathogen identification, targeted antibiotic therapy
• Risks: Bleeding, persistent perforation (rare), ossicular damage (very rare if correct technique)

---

6. Management

Management Philosophy

Modern AOM management balances:

1. Symptomatic relief (primary goal)
2. Antibiotic stewardship (avoiding unnecessary antibiotics)
3. Prevention of complications (rare but serious)
4. Patient/parent satisfaction and safety

Evidence Base: [7,8,9]

• Natural history: 60-80% of AOM cases resolve spontaneously within 2-3 days
• Antibiotic benefit: NNT 7-8 to prevent one child having pain at 2-7 days; NNT 20 to prevent one TM perforation
• Antibiotic harm: NNT 14 for one child to experience adverse effects (diarrhea, rash)
• Delayed antibiotics: Non-inferior to immediate antibiotics for most children; reduces antibiotic use by 50-75%

Management Algorithm

┌─────────────────────────────────────────────────────────┐
│         ACUTE OTITIS MEDIA SUSPECTED                    │
│   (Ear pain, fever, irritability, preceding URTI)      │
└─────────────────────────┬───────────────────────────────┘
                          ↓
┌─────────────────────────────────────────────────────────┐
│         CONFIRM DIAGNOSIS (Otoscopy ± Pneumatic)        │
│  - Middle ear effusion (bulging/immobile TM/otorrhea)   │
│  - Acute inflammation (otalgia/marked erythema)         │
└─────────────────────────┬───────────────────────────────┘
                          ↓
                  ┌───────┴───────┐
                  │  AOM CONFIRMED │
                  └───────┬────────┘
                          ↓
┌─────────────────────────────────────────────────────────┐
│              ASSESS FOR RED FLAGS                       │
│  🚩 Mastoiditis (postauricular swelling/erythema)       │
│  🚩 Facial nerve palsy                                  │
│  🚩 Meningism (neck stiffness, altered consciousness)   │
│  🚩 Systemically unwell / sepsis                        │
│  🚩 Age less than 3 months with fever                            │
└─────────────────────────┬───────────────────────────────┘
                          ↓
              ┌───────────┴───────────┐
              │   RED FLAGS PRESENT?  │
              └───┬────────────────┬──┘
                YES              NO
                  │                │
                  ↓                ↓
      ┌─────────────────┐  ┌─────────────────────┐
      │ URGENT REFERRAL │  │ ASSESS SEVERITY &   │
      │  - Emergency     │  │ IMMEDIATE ANTIBIOTIC│
      │    admission for │  │ INDICATIONS         │
      │    complications │  └──────────┬──────────┘
      │  - IV antibiotics│             │
      │  - ENT/Neuro     │             ↓
      │    involvement   │  ┌──────────────────────────────┐
      └──────────────────┘  │ IMMEDIATE ANTIBIOTICS if:    │
                            │  • Age less than 2 years + bilateral  │
                            │  • Otorrhea (perforated TM)  │
                            │  • Severe symptoms:          │
                            │    - Severe otalgia > 48h     │
                            │    - Fever ≥39°C             │
                            │    - Inconsolable crying     │
                            │  • Immunocompromised         │
                            └──────────┬───────────────────┘
                                       │
                        ┌──────────────┴──────────────┐
                        │  Meets criteria?            │
                        └────┬──────────────────┬─────┘
                           YES                 NO
                            │                   │
                            ↓                   ↓
        ┌─────────────────────────┐   ┌────────────────────┐
        │ IMMEDIATE ANTIBIOTICS   │   │ WATCHFUL WAITING   │
        │  First-line:            │   │ (Age ≥2, unilateral│
        │   AMOXICILLIN           │   │  mild AOM)         │
        │  • High-dose areas:     │   │                    │
        │    80-90 mg/kg/day ÷TID │   │ • Analgesia        │
        │  • Standard-dose:       │   │ • Safety-net       │
        │    40-50 mg/kg/day ÷TID │   │ • Delayed Rx       │
        │  • Duration: 5-10 days  │   │ • Review 48-72h    │
        │                         │   └─────────┬──────────┘
        │  Penicillin allergy:    │             │
        │   CLARITHROMYCIN        │             │
        │   or AZITHROMYCIN       │             │
        └────────────┬────────────┘             │
                     │                           │
                     └───────────┬───────────────┘
                                 ↓
                     ┌───────────────────────┐
                     │ FOLLOW-UP & REVIEW    │
                     │  • 48-72
h: Improving? │
                     │  • If worse/no better:│
                     │    - Reassess         │
                     │    - Start/change Abx │
                     │  • If improving:      │
                     │    - Complete course  │
                     │    - Routine f/u only │
                     │      if complications │
                     └───────────────────────┘

Symptomatic Management (ALL Patients)

Analgesia and Antipyretics

First-line (offer to ALL children with AOM): [9]

Adjunctive Measures:

• Warm compress to affected ear (comfort measure)
• Elevated head position for sleep (reduces middle ear pressure)
• Adequate hydration (especially if febrile)
• Rest

NOT Recommended: [9,23]

• ❌ Topical analgesic ear drops (benzocaine/lidocaine): Limited evidence; risk of allergic reaction
• ❌ Decongestants (oral or nasal): No evidence of benefit; potential harms [23]
• ❌ Antihistamines: No evidence of benefit [23]
• ❌ Corticosteroids: No evidence of benefit

Antibiotic Therapy

Indications for IMMEDIATE Antibiotics [9]

Absolute Indications:

Relative Indications (clinical judgment):

Watchful Waiting (Delayed Antibiotic Strategy) [7,8,9]

Suitable for:

• Age ≥2 years
• Unilateral AOM
• Mild symptoms (mild otalgia less than 48h, fever less than 39°C)
• No otorrhea
• Child not systemically unwell
• Reliable parents who can monitor and return if needed
• Access to healthcare for follow-up

Strategy Components:

1. Analgesia (paracetamol ± ibuprofen)
2. Safety-net advice (detailed verbal and written)
3. Delayed prescription (to use if not improving by 48-72h or worsening)
4. Follow-up plan (return if concerns or not improving)

Safety-Net Advice (CRITICAL for watchful waiting):

"Return to doctor or seek urgent care if":

• Symptoms worsen at any time
• Symptoms not improving by 48-72 hours
• Child becomes very unwell (lethargic, not feeding, persistent high fever)
• New symptoms develop:
  • Swelling or redness behind the ear
  • Drooping of one side of the face
  • Severe headache
  • Stiff neck
  • Rash that doesn't fade with pressure
  • Discharge from the ear

Evidence for Watchful Waiting: [7,8,24,33]

• Cochrane meta-analysis: Immediate vs delayed antibiotics showed no difference in pain at 3-7 days; delayed prescription reduced antibiotic use by 50-75% [7]
• Dutch study: Delayed prescription strategy safe and effective; complication rates unchanged [24]
• Pediatric Infectious Diseases Journal: Delayed vs immediate antibiotics in children 6 months-3 years with non-severe AOM showed similar clinical outcomes [24,33]

First-Line Antibiotic: Amoxicillin [9,10,11]

Why Amoxicillin?

• Narrow spectrum (targets S. pneumoniae, susceptible H. influenzae)
• Excellent middle ear fluid penetration
• Good safety profile
• Low cost
• Palatable suspension
• Overcomes intermediate pneumococcal resistance at high doses
• Guideline-recommended (NICE, AAP, IDSA)

Dosing:

High-Dose Rationale: [10,11]

• Pneumococcal resistance: Intermediate resistance (MIC 0.12-1.0 μg/mL) overcome by high-dose amoxicillin achieving middle ear fluid concentrations > 2-4 μg/mL
• Regional variation: Use high-dose if local S. pneumoniae resistance > 10%
• Risk factors for resistance: Recent antibiotics (less than 30 days), daycare attendance, age less than 2 years

Duration: [9]

• 5 days: Age ≥2 years, mild-moderate AOM, no perforation (non-inferior to 10 days; reduces adverse effects)
• 7 days: Alternative for age ≥2 years
• 10 days: Age less than 2 years, severe AOM, perforation, recurrent AOM, immunocompromised

Amoxicillin Formulations (examples; vary by region):

• Oral suspension: 125 mg/5 mL, 250 mg/5 mL
• Capsules/tablets: 250 mg, 500 mg
• Dosing example: 20 kg child, high-dose (80 mg/kg/day) = 1600 mg/day = 530 mg TID ≈ 10 mL of 250 mg/5 mL suspension TID

Second-Line Antibiotics

Indications:

1. Amoxicillin failure (no improvement or worsening after 48-72h)
2. Recent amoxicillin use (less than 30 days; increased resistance risk)
3. Suspected beta-lactamase producers (NTHi, M. catarrhalis)

Penicillin Allergy Alternatives

Note: Always confirm true allergy history; many reported "penicillin allergies" are childhood rashes, not true IgE-mediated reactions.

Treatment Failure (No Improvement at 48-72h)

Reassess:

1. Confirm diagnosis: Repeat otoscopy; could it be OME, otitis externa, viral, referred pain?
2. Compliance: Is medication being given correctly?
3. Complications: Examine for mastoiditis, severe disease

Management:

Recurrent AOM

Definition: ≥3 episodes in 6 months OR ≥4 episodes in 12 months

Management:

Grommets (Tympanostomy Tubes): [18,32]

• Mechanism: Bypass Eustachian tube dysfunction; ventilate middle ear; allow drainage
• Effect on AOM: Reduces episodes by ~1-1.5 per 6 months while tubes in situ
• Indications: Recurrent AOM (≥3 in 6 months or ≥4 in 12 months) AND bilateral OME \u003e 3 months AND hearing loss/speech delay
• Complications: Otorrhea (12-26%), persistent perforation (2-3%), tympanosclerosis (35-65%, usually asymptomatic), cholesteatoma (rare, less than 1%)

---

7. Complications

Incidence: Overall complications have declined dramatically since the antibiotic era (less than 1-5% overall), but recent increases noted post-pandemic. [12,13]

Tympanic Membrane Perforation

Incidence: 5-15% of AOM cases [14]

Mechanism: Accumulating purulent effusion increases middle ear pressure beyond tympanic membrane tensile strength → rupture

Presentation:

• Sudden onset purulent otorrhea (yellow, green, or blood-tinged discharge)
• Often immediate pain relief (pressure decompression)
• May have preceding severe otalgia

Examination:

• Purulent discharge in external canal
• Visible perforation (usually pars tensa, anteroinferior quadrant)
• Pulsatile discharge (in active infection)

Outcomes: [14]

• > 90% heal spontaneously within 2-4 weeks
• Persistent perforation (less than 10%): Risk factors include large perforation (> 2 mm), recurrent perforations, chronic OME
• Hearing: Temporary conductive loss (10-30 dB) until perforation heals

Management:

• Antibiotics: Immediate antibiotic therapy indicated (topical ± oral)
• Topical antibiotics: Ciprofloxacin 0.3% ear drops (avoid ototoxic aminoglycosides)
• Oral antibiotics: Amoxicillin or co-amoxiclav
• Ear precautions: Keep ear dry (no swimming); avoid water entry
• Follow-up: Reassess at 6-8 weeks to confirm healing

Referral to ENT: Persistent perforation > 3 months; recurrent perforations; conductive hearing loss

Acute Mastoiditis

Incidence: 1-4 per 100,000 children; increasing post-pandemic [12,13]

Definition: Infection and inflammation of the mastoid air cells (posterior to middle ear)

Pathophysiology: [12]

1. AOM → infection spreads posteriorly into mastoid air cells
2. Purulent material accumulates → bony septa destruction (coalescent mastoiditis)
3. Subperiosteal abscess formation (between bone and periosteum)
4. Potential intracranial extension

Risk Factors:

• Young age (less than 2 years)
• Delayed/inadequate antibiotic treatment
• Highly virulent organisms (S. pyogenes, S. aureus)
• Immunodeficiency

Clinical Presentation: [12,13]

Examination: TM usually bulging or perforated; erythematous external canal; sagging of posterior-superior canal wall (late sign)

Investigations: [12]

Management: [12,13]

All cases → Urgent ENT referral + Hospital admission

Complications of Mastoiditis:

• Subperiosteal abscess (most common complication)
• Facial nerve palsy (7%)
• Labyrinthitis (hearing loss, vertigo)
• Petrositis (Gradenigo syndrome: triad of otorrhea, retro-orbital pain, abducens palsy)
• Intracranial: meningitis, epidural abscess, subdural empyema, brain abscess, sigmoid sinus thrombosis

Prognosis: Excellent with early recognition and treatment; mortality less than 1% in developed countries

Intracranial Complications (Rare, less than 0.1%)

Types: [12]

Mortality: 5-10% despite treatment; long-term neurological sequelae in 10-50% of survivors

Facial Nerve Palsy

Incidence: 0.5-1% of AOM; 5-7% of mastoiditis [12]

Mechanism: Inflammation/infection near facial nerve canal (which traverses middle ear and mastoid); congenital dehiscence of facial nerve canal (10-20% of children)

Presentation:

• Sudden onset unilateral facial weakness (House-Brackmann grade I-VI)
• Incomplete eye closure, droop of mouth, inability to wrinkle forehead (lower motor neuron pattern)
• Associated AOM or mastoiditis

Management:

• Urgent ENT referral
• IV antibiotics (broad-spectrum)
• Myringotomy (drainage/decompression)
• Corticosteroids (controversial; often given)
• Eye protection (lubricating drops, taping eye at night)

Prognosis: 90-95% complete recovery with prompt treatment

Labyrinthitis (Suppurative)

Incidence: Rare (less than 0.5%)

Mechanism: Infection spreads to inner ear via round window, oval window, or bony erosion

Presentation:

• Severe vertigo
• Sensorineural hearing loss (sudden onset)
• Nausea/vomiting
• Nystagmus (towards affected ear initially, then away)

Investigation:

• Audiometry: Sensorineural hearing loss
• CT temporal bones: Rule out labyrinthine fistula, cholesteatoma
• MRI IAM (internal auditory meatus): Rule out acoustic neuroma

Management:

• Urgent ENT referral
• IV antibiotics
• Corticosteroids (oral prednisolone 1 mg/kg for SSNHL)
• Antiemetics (for vertigo)

Prognosis: Permanent sensorineural hearing loss in 50-80%; vertigo usually resolves

Chronic Suppurative Otitis Media (CSOM)

Definition: Persistent ear discharge (> 6 weeks) through a perforated TM

Pathophysiology: Persistent perforation + ongoing bacterial infection (Pseudomonas aeruginosa, S. aureus, polymicrobial)

Presentation:

• Chronic purulent otorrhea (intermittent or continuous)
• Conductive hearing loss
• Usually painless (unless acute exacerbation)

Management:

• Aural toilet (microsuction)
• Topical antibiotics (ciprofloxacin drops)
• Avoid water entry
• ENT referral: Consider tympanoplasty (surgical TM repair)

Hearing Loss

Temporary Conductive Hearing Loss (50-70% during AOM): [1,2]

• Mechanism: Middle ear effusion blocks sound transmission
• Severity: Mild-moderate (20-40 dB)
• Duration: Resolves as effusion clears (days to weeks)
• Concern: Bilateral prolonged effusion (> 3 months) → speech/language delay risk in young children

Persistent OME (30-40% post-AOM): [2]

• Definition: Effusion persists > 3 months after AOM resolution
• Management: Watchful waiting for 3 months; if persists + bilateral + hearing loss/speech concerns → consider grommets
• Audiometry: Indicated if OME > 3 months

Permanent Sensorineural Hearing Loss (rare, less than 1%):

• From labyrinthitis or meningitis complication

Cholesteatoma

Definition: Abnormal growth of keratinizing squamous epithelium in middle ear

Mechanism: Chronic negative middle ear pressure → TM retraction → squamous epithelium migration into middle ear

Association with AOM: Recurrent AOM and chronic OME are risk factors

Presentation:

• Chronic foul-smelling otorrhea
• Conductive hearing loss
• Painless (usually)
• Retraction pocket or attic perforation on otoscopy
• White debris (keratin)

Complications: Bony erosion (ossicles, tegmen, facial nerve canal) → hearing loss, facial palsy, intracranial infection

Management: ENT referral; surgical excision (mastoidectomy)

---

8. Prognosis and Outcomes

Natural History

Factors Affecting Prognosis

Better Prognosis (higher spontaneous resolution):

• Age ≥2 years
• Unilateral AOM
• Mild symptoms
• No perforation
• Immunocompetent
• No craniofacial abnormalities

Worse Prognosis (lower spontaneous resolution, higher recurrence):

• Age less than 2 years (especially less than 6 months)
• Bilateral AOM
• Severe symptoms
• Perforation/otorrhea
• Daycare attendance
• Recurrent URTI
• Craniofacial abnormalities
• Immunodeficiency
• Family history of recurrent AOM

Long-Term Outcomes

Economic Impact

• Leading cause of GP visits for children in developed countries
• Leading cause of antibiotic prescriptions for children
• Parental work absence: Average 2-3 days per episode
• Healthcare costs: Billions annually (direct and indirect)

---

9. Prevention

Primary Prevention

Vaccination

Pneumococcal Conjugate Vaccine (PCV13)

Mechanism: Induces antibodies against 13 pneumococcal capsular polysaccharides (serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, 23F)

Effectiveness for AOM: [17,27]

• Overall AOM incidence: Reduced by 6-8% (all-cause AOM, modest effect)
• Pneumococcal AOM: Reduced by 40-60% for vaccine serotypes
• Serotype-specific AOM: Near-elimination of vaccine-serotype disease
• Severe/complicated AOM: Reduced mastoiditis incidence by 30-40% (initial post-PCV7 era)
• Limitation: Serotype replacement (non-vaccine serotypes, especially 3 with PCV13, and NTHi increase) [28,29,30]

Schedule: 2, 4, 6, and 12-15 months (varies by country)

Impact: Transformative for overall pneumococcal disease (invasive pneumococcal disease reduced by > 90%); modest for AOM due to multiple pathogens and serotype replacement

Influenza Vaccine

Effectiveness for AOM: [2]

• RR reduction 0.7-0.85 for influenza-associated AOM during influenza season
• Reduces overall AOM episodes by ~5-10% annually
• Greatest impact during influenza outbreaks

Schedule: Annual (autumn/fall); live attenuated (intranasal) or inactivated (IM)

Recommendation: All children ≥6 months

Other Vaccines

• Hib vaccine (Haemophilus influenzae type b): Eliminated Hib AOM (but no effect on nontypeable H. influenzae)
• COVID-19 vaccine: Potential reduction in respiratory infections and secondary AOM (emerging data)

Tertiary Prevention (Preventing Recurrence)

See Recurrent AOM section in Management.

Evidence-Based Strategies:

1. Grommets (tympanostomy tubes): ≥3 episodes in 6 months or ≥4 in 12 months + persistent bilateral OME [18,32]
2. Modify risk factors: Reduce daycare, eliminate smoke exposure, encourage breastfeeding, remove pacifier (\u003e 12 months) [15,26,31]
3. Ensure vaccination: PCV13 and annual influenza [17,27]
4. Avoid antibiotic prophylaxis: NOT routinely recommended (resistance concerns, limited efficacy) [9]

Ineffective Strategies (not recommended):

• ❌ Antibiotic prophylaxis (routine)
• ❌ Adenoidectomy (alone, without grommets; exception: age > 4 with obstructive symptoms)
• ❌ Homeopathy, herbal remedies (no evidence)
• ❌ Xylitol (limited evidence; logistical challenges)

---

10. Evidence and Guidelines

Key Guidelines

Guideline Convergence: All major guidelines (NICE, AAP, Canadian) now support:

1. Accurate diagnosis (require effusion + acute inflammation)
2. Selective antibiotic use (watchful waiting for suitable cases)
3. Amoxicillin first-line (high-dose in resistance areas)
4. Shorter courses for age ≥2 years (5 days vs 10 days)

Landmark Evidence

Cochrane Reviews

1. Antibiotics for acute otitis media in children (2013) [7]

• Studies: 13 RCTs, > 3,000 children
• Findings:
  • Pain at 24 h: No significant difference (antibiotics vs placebo)
  • "Pain at 2-7 days: RR 0.70 (NNT 7-8 for benefit)"
  • "TM perforation: RR 0.37 (NNT ~20)"
  • "Contralateral AOM: RR 0.49"
  • "Adverse effects (diarrhea/rash): NNT 14 for harm"
• Conclusion: Antibiotics provide modest benefit; selective use justified

2. Delayed versus immediate antibiotics for acute otitis media (meta-analysis) [8]

• Studies: 5 RCTs, > 1,200 children
• Findings:
  • No difference in pain at 3-7 days (delayed vs immediate)
  • Antibiotic use reduced by 50-75% with delayed prescription
  • No difference in complications
• Conclusion: Delayed prescription safe and reduces antibiotic consumption

Randomized Controlled Trials

3. Finnish study: Delayed vs immediate antibiotics in children 6 months-3 years [8]

• Design: RCT, 283 children, non-severe AOM
• Findings: Clinical failure rates similar (delayed 26% vs immediate 18%, not statistically significant); reduced antibiotic use with delayed approach
• Conclusion: Delayed prescription non-inferior for non-severe AOM

4. High-dose vs standard-dose amoxicillin [10,11]

• Studies: Multiple trials
• Findings: High-dose (80-90 mg/kg/day) superior to standard-dose in areas with pneumococcal resistance > 10%; achieves middle ear fluid MIC > 90th percentile for intermediate-resistance S. pneumoniae
• Conclusion: Use high-dose in resistance areas or high-risk children

Observational Studies

5. Natural history of untreated AOM (Rosenfeld & Kay meta-analysis) [8]

• Studies: 8 studies, > 2,000 children
• Findings: Spontaneous resolution 60-80%; younger age, bilateral disease, and severity predict lower resolution rates
• Conclusion: Most AOM self-limiting; justifies watchful waiting

6. PCV impact on AOM (multiple studies) [17,27,28,29]

• Findings: Overall AOM incidence reduced 6-8%; vaccine-serotype AOM reduced 40-60%; serotype replacement with 19A (PCV7) and NTHi [28,29,30]
• Conclusion: PCV13 provides modest but important AOM reduction

---

11. Patient and Layperson Explanation

What is Acute Otitis Media?

Acute otitis media (AOM) is an ear infection that affects the middle part of your child's ear, which is the space behind the eardrum. It's one of the most common infections in young children, especially those under 3 years old.

What causes it?

Your child's ear infection usually starts with a cold or flu. The cold causes swelling in the nose and throat, which can block a small tube (called the Eustachian tube) that connects the back of the nose to the ear. When this tube gets blocked, fluid builds up behind the eardrum. Germs (bacteria or viruses) from the nose can then get into this fluid and cause an infection.

Why are young children more likely to get ear infections?

Young children's Eustachian tubes are shorter, wider, and more horizontal than adults', which makes it easier for germs to reach the middle ear. Also, young children's immune systems are still developing, so they catch more colds, which can lead to ear infections.

What are the symptoms?

Your child may:

• Complain of ear pain (older children), or tug/rub their ear (babies and toddlers)
• Be irritable or cry more than usual, especially at night
• Have a fever (temperature above 38°C/100.4°F)
• Have trouble sleeping or eating
• Be generally unwell, with a runny nose or cough (from the preceding cold)
• Sometimes have fluid draining from the ear (if the eardrum has a small hole/burst)

How is it diagnosed?

Your doctor will look in your child's ear with a special light (otoscope) to examine the eardrum. In an ear infection, the eardrum is usually red, swollen outward (bulging), and cloudy. This examination is usually all that's needed—no blood tests or scans are required for most ear infections.

Does my child need antibiotics?

Not always. Many ear infections get better on their own within 2-3 days without antibiotics. Your doctor might suggest:

Watchful Waiting (for children over 2 years with mild symptoms)

• Give your child pain relief medicine (paracetamol or ibuprofen) regularly
• Keep your child comfortable
• Watch for signs of improvement
• Your doctor may give you an antibiotic prescription to use only if your child doesn't improve within 2-3 days

Antibiotics Straightaway (if needed)

Your doctor will usually prescribe immediate antibiotics if:

• Your child is under 2 years old and has infection in both ears
• There is fluid draining from the ear
• Your child is very unwell or has a high fever
• Your child has severe ear pain that's been going on for more than 2 days

The usual antibiotic is amoxicillin (a liquid medicine), given three times a day for 5-10 days. It's very important to finish the whole course even if your child feels better. [9,10]

How can I help my child feel better?

• Give paracetamol or ibuprofen regularly for pain and fever (follow the dosing on the bottle for your child's age/weight)
• Keep your child hydrated (offer drinks regularly)
• Let your child rest
• Prop up your child's head slightly when sleeping (use an extra pillow for older children) to help drainage
• A warm compress (like a warm flannel) held gently against the ear may soothe

When should I seek help urgently?

Take your child to A&E or call 999/911 if:

• There is swelling or redness behind the ear
• One side of your child's face droops
• Your child has a stiff neck, severe headache, or is drowsy/confused
• Your child is very unwell or difficult to wake
• Your child develops a rash that doesn't fade when you press a glass against it

When should I see my doctor again?

See your doctor (routine appointment) if:

• Your child's symptoms get worse at any time
• Your child is not improving within 2-3 days
• Your child still has symptoms after finishing the antibiotics
• Fluid is still draining from the ear after 2 weeks

Will my child's hearing be affected?

Many children have temporary mild hearing loss during and for a few weeks after an ear infection, because of fluid behind the eardrum. This usually goes away as the fluid clears. If you're concerned about your child's hearing after 3 months, see your doctor—a hearing test might be needed.

Can ear infections be prevented?

You can reduce the risk by:

• Breastfeeding your baby (if possible)
• Keeping your child away from cigarette smoke
• Not propping the bottle for feeding (hold your baby upright)
• Making sure your child has their vaccinations (including pneumococcal and flu vaccines)
• Reducing pacifier use after 12 months of age

What if my child keeps getting ear infections?

Some children get ear infections repeatedly (3 or more in 6 months). If this happens, your doctor might:

• Check for underlying causes (allergies, enlarged adenoids)
• Refer your child to an ear, nose, and throat (ENT) specialist
• Consider grommets (tiny tubes placed in the eardrum to help drainage and ventilation)

Will my child grow out of it?

Yes! Most children stop getting frequent ear infections by age 5-7 years as their Eustachian tubes mature and their immune systems develop.

---

12. References

Primary Sources

1. Leung AKC, Wong AHC. Acute Otitis Media in Children. Recent Pat Inflamm Allergy Drug Discov. 2017;11(1):32-40. PMID: 28707578.

2. Schilder AGM, Chonmaitree T, Cripps AW, et al. Otitis media. Nat Rev Dis Primers. 2016 Sep 8;2:16063. PMID: 27604644.

3. Rovers MM, Schilder AGM, Zielhuis GA, Rosenfeld RM. Otitis media. Lancet. 2004 Feb 7;363(9407):465-73. PMID: 14962529.

4. Ngo CC, Massa HM, Thornton RB, Cripps AW. Predominant bacteria detected from the middle ear fluid of children experiencing otitis media: a systematic review. PLoS One. 2016 Mar 9;11(3):e0150949. PMID: 26959819.

5. Lieberthal AS, Carroll AE, Chonmaitree T, et al. The diagnosis and management of acute otitis media. Pediatrics. 2013 Mar;131(3):e964-99. PMID: 23439909.

6. Rothman R, Owens T, Simel DL. Does this child have acute otitis media? JAMA. 2003 Sep 24;290(12):1633-40. PMID: 14506123.

7. Venekamp RP, Sanders SL, Glasziou PP, Del Mar CB, Rovers MM. Antibiotics for acute otitis media in children. Cochrane Database Syst Rev. 2015 Jun 23;(6):CD000219. PMID: 26099233.

8. Rosenfeld RM, Kay D. Natural history of untreated otitis media. Laryngoscope. 2003 Oct;113(10):1645-57. PMID: 14520089.

9. National Institute for Health and Care Excellence. Otitis media (acute): antimicrobial prescribing (NG91). 2018. Available at: https://www.nice.org.uk/guidance/ng91

10. Garbutt J, St Geme JW 3rd, May A, Storch GA, Shackelford PG. Developing community-specific recommendations for first-line treatment of acute otitis media: is high-dose amoxicillin necessary? Pediatrics. 2004 Feb;113(2):342-7. PMID: 14754946.

11. Chu CH, Wang MC, Lin LY, Liu CY, Chen YJ, Lee MY. High-dose amoxicillin with clavulanate for the treatment of acute otitis media in children. ScientificWorldJournal. 2013 Dec 30;2013:157020. PMID: 24523659.

12. Kangsanarak J, Fooanant S, Ruckphaopunt K, Navacharoen N, Teotrakul S. Extracranial and intracranial complications of suppurative otitis media. Report of 102 cases. J Laryngol Otol. 1993 Nov;107(11):999-1004. PMID: 8288994.

13. Hollborn H, Lachmann C, Strüder D, Harnisch W, Zahnert T, Neudert M. Rise in complications of acute otitis media during and after the COVID-19 pandemic. Eur Arch Otorhinolaryngol. 2024 Sep;281(9):4613-4619. PMID: 38709319.

14. Holt JJ, Ambro BT. Spontaneous tympanic membrane perforation in acute otitis media. JAMA Otolaryngol Head Neck Surg. 2015 Aug;141(8):740-1. PMID: 26203494.

15. Paradise JL, Rockette HE, Colborn DK, et al. Otitis media in 2253 Pittsburgh-area infants: prevalence and risk factors during the first two years of life. Pediatrics. 1997 Mar;99(3):318-33. PMID: 9041282.

16. Duncan B, Ey J, Holberg CJ, Wright AL, Martinez FD, Taussig LM. Exclusive breast-feeding for at least 4 months protects against otitis media. Pediatrics. 1993 May;91(5):867-72. PMID: 8474804.

17. Fortanier AC, Venekamp RP, de Hoog MLA, et al. Pneumococcal conjugate vaccines for preventing otitis media. Cochrane Database Syst Rev. 2019 May 15;5(5):CD001480. PMID: 31087327.

18. Browning GG, Rovers MM, Williamson I, Lous J, Burton MJ. Grommets (ventilation tubes) for hearing loss associated with otitis media with effusion in children. Cochrane Database Syst Rev. 2010 Oct 6;(10):CD001801. PMID: 20927726.

19. Gaddey HL, Wright MT, Nelson TN. Otitis Media: Rapid Evidence Review. Am Fam Physician. 2019 Sep 15;100(6):350-356. PMID: 31524361.

20. Tähtinen PA, Laine MK, Ruuskanen O, Ruohola A. Delayed versus immediate antimicrobial treatment for acute otitis media. Pediatr Infect Dis J. 2012 Dec;31(12):1227-32. PMID: 22760531.

21. Shaikh N, Hoberman A, Kaleida PH, et al. Videos in clinical medicine. Diagnosing otitis media--otoscopy and cerumen removal. N Engl J Med. 2010 Nov 18;363(21):e15. PMID: 21083379.

22. Hoberman A, Paradise JL, Rockette HE, et al. Treatment of acute otitis media in children under 2 years of age. N Engl J Med. 2011 Jan 13;364(2):105-15. PMID: 21226576.

23. Coleman C, Moore M. Decongestants and antihistamines for acute otitis media in children. Cochrane Database Syst Rev. 2008 Jul 16;(3):CD001727. PMID: 18646076.

24. Spiro DM, Tay KY, Arnold DH, Dziura JD, Baker MD, Shapiro ED. Wait-and-see prescription for the treatment of acute otitis media: a randomized controlled trial. JAMA. 2006 Sep 13;296(10):1235-41. PMID: 16968847.

25. Coker TR, Chan LS, Newberry SJ, et al. Diagnosis, microbial epidemiology, and antibiotic treatment of acute otitis media in children: a systematic review. JAMA. 2010 Nov 17;304(19):2161-9. PMID: 21081729.

26. Marchisio P, Cantarutti L, Sturkenboom M, et al. Burden of acute otitis media in primary care pediatrics in Italy: a secondary data analysis from the Pedianet database. BMC Pediatr. 2012 Nov 23;12:185. PMID: 23176441.

27. Taylor S, Marchisio P, Vergison A, Harriague J, Hausdorff WP, Haggard M. Impact of pneumococcal conjugate vaccination on otitis media: a systematic review. Clin Infect Dis. 2012 Jun;54(12):1765-73. PMID: 22423127.

28. Pichichero ME, Casey JR. Emergence of a multiresistant serotype 19A pneumococcal strain not included in the 7-valent conjugate vaccine as an otopathogen in children. JAMA. 2007 Apr 25;297(16):1772-5. PMID: 17456820.

29. Block SL, Hedrick J, Harrison CJ, et al. Community-wide vaccination with the heptavalent pneumococcal conjugate significantly alters the microbiology of acute otitis media. Pediatr Infect Dis J. 2004 Sep;23(9):829-33. PMID: 15361720.

30. Casey JR, Adlowitz DG, Pichichero ME. New patterns in the otopathogens causing acute otitis media six to eight years after introduction of pneumococcal conjugate vaccine. Pediatr Infect Dis J. 2010 Apr;29(4):304-9. PMID: 19935445.

31. Klein JO. The burden of otitis media. Vaccine. 2000 Dec 8;19 Suppl 1:S2-8. PMID: 11163456.

32. Harmes KM, Blackwood RA, Burrows HL, Cooke JM, Harrison RV, Passamani PP. Otitis media: diagnosis and treatment. Am Fam Physician. 2013 Oct 1;88(7):435-40. PMID: 24134083.

33. McCormick DP, Chonmaitree T, Pittman C, et al. Nonsevere acute otitis media: a clinical trial comparing outcomes of watchful waiting versus immediate antibiotic treatment. Pediatrics. 2005 Jun;115(6):1455-65. PMID: 15930205.

34. Van Zuijlen DA, Schilder AG, Van Balen FA, Hoes AW. National differences in incidence of acute mastoiditis: relationship to prescribing patterns of antibiotics for acute otitis media? Pediatr Infect Dis J. 2001 Feb;20(2):140-4. PMID: 11224832.

---

13. Examination Focus

Common Exam Questions (MCQ/SBA)

Question 1: Diagnostic Finding

Q: A 14-month-old child presents with 24 hours of fever, irritability, and tugging at the right ear. Which otoscopic finding has the highest positive likelihood ratio for diagnosing acute otitis media?

A. Erythematous tympanic membrane
B. Opaque tympanic membrane
C. Bulging tympanic membrane
D. Air-fluid level behind tympanic membrane
E. Reduced tympanic membrane mobility

Answer: C. Bulging tympanic membrane (LR+ 51) [6]

Explanation: While all findings are associated with AOM, a bulging TM has the highest diagnostic accuracy (LR+ 51), making it the single most important finding. Erythema alone is the least specific (crying, fever cause physiologic erythema). Reduced mobility (assessed by pneumatic otoscopy) also has high accuracy (LR+ 31) but is technique-dependent.

---

Question 2: Antibiotic Indications

Q: Which of the following children with confirmed acute otitis media should receive immediate antibiotics according to current guidelines?

A. 3-year-old with unilateral AOM, mild otalgia for 24h, temperature 38.2°C
B. 18-month-old with bilateral AOM, moderate otalgia, temperature 38.8°C
C. 4-year-old with unilateral AOM, moderate otalgia for 36h, temperature 39.1°C
D. 5-year-old with unilateral AOM, mild otalgia, temperature 38.5°C
E. 3-year-old with unilateral AOM, mild otalgia, no fever

Answer: B. 18-month-old with bilateral AOM [9]

Explanation: Age less than 2 years + bilateral AOM is an absolute indication for immediate antibiotics (guideline recommendation). Options A, D, E are suitable for watchful waiting (age ≥2 years, unilateral, mild-moderate symptoms). Option C is borderline (severe symptoms) but age ≥2 and unilateral could still justify watchful waiting with safety-netting, though some clinicians would treat immediately.

---

Question 3: First-Line Antibiotic

Q: A 2-year-old child requires antibiotic therapy for acute otitis media (no drug allergies). What is the first-line antibiotic and appropriate dosing in an area with 15% pneumococcal resistance to penicillin?

A. Amoxicillin 40 mg/kg/day divided TID for 5 days
B. Amoxicillin 80 mg/kg/day divided TID for 5 days
C. Co-amoxiclav 40 mg/kg/day divided BID for 5 days
D. Clarithromycin 15 mg/kg/day divided BID for 5 days
E. Ceftriaxone 50 mg/kg IM once daily for 3 days

Answer: B. Amoxicillin 80 mg/kg/day divided TID for 5 days [10,11]

Explanation: High-dose amoxicillin (80-90 mg/kg/day) is first-line in areas with pneumococcal resistance > 10%, achieving middle ear concentrations that overcome intermediate resistance. Duration is 5 days for age ≥2 years. Standard-dose (40-50 mg/kg/day) is used in low-resistance areas. Co-amoxiclav is second-line (beta-lactamase producers). Clarithromycin is for penicillin allergy. Ceftriaxone is for severe disease/inability to take oral medications.

---

Question 4: Red Flag Complication

Q: A 15-month-old child presents with acute otitis media diagnosed 5 days ago. Today, the parents note postauricular swelling and redness with the ear pushed outward. Temperature is 39.5°C. What is the most likely diagnosis and immediate management?

A. Uncomplicated AOM; continue oral antibiotics
B. Mastoiditis; urgent ENT referral and hospital admission
C. Otitis externa; topical antibiotics
D. Mumps; supportive care
E. Lymphadenitis; oral antibiotics

Answer: B. Mastoiditis; urgent ENT referral and hospital admission [12,13]

Explanation: Postauricular erythema, swelling, tenderness, and lateral/downward displacement of the auricle are pathognomonic for acute mastoiditis—a surgical emergency. Immediate management includes urgent ENT referral, hospital admission, IV antibiotics, and CT temporal bones. This is the key red flag complication of AOM.

---

Viva Voce Points

Viva Scenario: "A mother brings her 10-month-old child with 2 days of fever and irritability. You diagnose acute otitis media. Walk me through your management."

Model Answer Structure:

1. Confirm Diagnosis

"I would take a focused history: onset, fever, ear symptoms, preceding URTI, feeding, sleeping. Then examine both ears with otoscopy—I'm looking for the hallmark finding of a bulging tympanic membrane, which is the most specific sign (LR+ 51). I'd also assess for erythema, opacity, and ideally check tympanic membrane mobility with pneumatic otoscopy. I'd also exclude red flags: postauricular swelling (mastoiditis), facial asymmetry (facial nerve palsy), or meningism."

2. Assess Severity and Indications for Antibiotics

"At 10 months, the child is under 2 years old. I'd assess whether it's unilateral or bilateral AOM—this is critical because bilateral AOM in a child under 2 is an absolute indication for immediate antibiotics according to NICE and AAP guidelines. I'd also check for otorrhea (perforation), severe symptoms, or if the child is systemically unwell—all of which warrant immediate antibiotics."

3. Explain Antibiotic vs Watchful Waiting Rationale

"If it's bilateral, I'd prescribe antibiotics immediately. If it's unilateral and mild, watchful waiting could be considered, but given the age (under 2), most guidelines lean towards immediate treatment. I'd explain to the parents that about 60-80% of ear infections resolve spontaneously, but younger children and those with bilateral disease have lower spontaneous resolution rates, so antibiotics can help reduce the duration of symptoms and prevent complications like perforation."

4. First-Line Antibiotic Choice

"First-line is amoxicillin. In our area, if there's high pneumococcal resistance (> 10%), I'd use high-dose amoxicillin 80-90 mg/kg/day divided three times daily. For this 10-month-old weighing, say, 9 kg, that's roughly 720-810 mg/day, or about 240-270 mg three times a day. Duration would be 10 days given the child is under 2 years. I'd use oral suspension (e.g., 250 mg/5 mL)."

5. Symptomatic Management

"Equally important is analgesia: I'd prescribe regular paracetamol (15 mg/kg every 4-6 hours) and ibuprofen (10 mg/kg every 6-8 hours) for fever and pain. I'd advise the parents on keeping the child hydrated, comfortable, and elevating the head slightly for sleep."

6. Safety-Netting

"I'd provide robust safety-net advice: return immediately if the child develops postauricular swelling or redness, facial droop, neck stiffness, severe lethargy, or becomes very unwell. Also return if symptoms worsen or don't improve within 48-72 hours despite antibiotics. I'd arrange follow-up in 2-3 days to reassess."

7. Follow-Up and Hearing

"After the acute episode, I'd advise that hearing might be temporarily reduced due to middle ear effusion, which can persist for weeks to months. If the effusion hasn't cleared by 3 months, or if there are concerns about hearing, speech, or recurrent infections, I'd refer for audiology and ENT assessment."

---

Viva Follow-Up Questions:

Q: "What are the common bacterial pathogens in AOM, and how has PCV vaccination changed the epidemiology?"

A:

"The main bacterial pathogens are Streptococcus pneumoniae (25-35% currently, down from 40-50% pre-PCV due to vaccine), nontypeable Haemophilus influenzae (30-50%, increasing proportionally), and Moraxella catarrhalis (10-15%). Streptococcus pyogenes (Group A Strep) accounts for 3-5% but can cause severe disease.

PCV13 vaccination has reduced overall AOM incidence by about 6-8% and vaccine-serotype pneumococcal AOM by 40-60%. However, there's been serotype replacement—non-vaccine serotypes (especially serotype 3) and NTHi have increased. Beta-lactamase production is common in NTHi and M. catarrhalis (30-50% and > 90% respectively), which is why co-amoxiclav is used as second-line therapy for treatment failures."

Q: "When would you refer to ENT?"

A:

"Urgent referral: Suspected mastoiditis (postauricular signs), facial nerve palsy, intracranial complications (meningism, severe headache, altered consciousness).

Routine referral: Recurrent AOM (≥3 episodes in 6 months or ≥4 in 12 months) with persistent bilateral OME and hearing loss—consider grommets. Persistent perforation beyond 6-8 weeks. Cholesteatoma suspected (chronic foul discharge, retraction pocket, keratin debris). Persistent conductive hearing loss affecting speech/language development."

Q: "What is the evidence for watchful waiting?"

A:

"Cochrane meta-analysis and multiple RCTs show that 60-80% of AOM cases resolve spontaneously. Antibiotics reduce pain at 2-7 days with an NNT of 7-8, and reduce perforation with an NNT of about 20. Delayed antibiotic prescription strategies (watchful waiting with a prescription to use if not improving by 48-72h) are non-inferior to immediate antibiotics for clinical outcomes in children ≥2 years with unilateral, non-severe AOM, and reduce antibiotic use by 50-75%. Crucially, no difference in complication rates was found. This supports selective antibiotic use to balance symptom relief with antimicrobial stewardship."

---

OSCE Scenario: Communication Station

Scenario: You are the GP. A mother presents with her 3-year-old child who has had ear pain and fever for 24 hours. You have diagnosed mild, unilateral acute otitis media. Explain your management plan to the mother.

Key Communication Points:

1. Diagnosis Explanation (simple language)

   • "Your child has an ear infection called acute otitis media. It's very common in young children."
   • "The infection is in the middle part of the ear, behind the eardrum."

2. Cause and Why Children Get It

   • "It usually happens after a cold. The cold causes swelling that blocks a tube connecting the nose to the ear, and fluid builds up. Germs from the nose can get into this fluid."
   • "Young children get ear infections more often because their tubes are shorter and more horizontal."

3. Natural History

   • "The good news is that most ear infections (about 7 or 8 out of 10) get better on their own within 2-3 days without antibiotics."

4. Watchful Waiting Approach

   • "Because your child is over 2, has infection in only one ear, and isn't severely unwell, we can use an approach called 'watchful waiting'."
   • "This means we treat the pain and fever, watch how your child does over the next 2-3 days, and only use antibiotics if needed."

5. Pain Relief (Priority)

   • "The most important thing right now is to keep your child comfortable and relieve the pain."
   • "Give paracetamol [dose] every 4-6 hours and ibuprofen [dose] every 6-8 hours. You can give both—they work well together."

6. Delayed Prescription

   • "I'm giving you a prescription for antibiotics to keep at home. Only use it if your child isn't improving by day 3, or if symptoms get worse."

7. Safety-Netting (CRITICAL)

   • "Most children improve quickly, but I need you to watch for warning signs and come back or call 111/999 if:
     • Your child gets worse at any time
     • Symptoms aren't improving by day 3
     • Swelling or redness appears behind the ear
     • You notice face drooping
     • Your child becomes very drowsy or unwell
     • Develops neck stiffness or severe headache"

8. Address Concerns (empathy, partnership)

   • "I know it's difficult to see your child in pain. Do you have any questions or worries?"
   • (Common concern: "Will my child's hearing be affected?")
     → "Hearing might be a bit muffled for a few weeks due to fluid, but it usually returns to normal as the fluid clears."

9. Follow-Up

   • "If you end up using the antibiotics, make sure to complete the full course. If symptoms persist beyond a week, or you're concerned about hearing after a few weeks, come back for a check."

---

14. Cross-References and Related Topics

Related MedVellum Topics

---

Medical Disclaimer: MedVellum content is for educational purposes and clinical reference. Clinical decisions should account for individual patient circumstances, local antibiotic resistance patterns, and up-to-date guidelines. Always consult appropriate specialists for complicated cases or when uncertain.

---

Document Quality Metrics:

• Total Lines: 1,612
• Total Citations: 34
• Target Audience: Medical students, paediatric trainees, GP trainees, MRCPCH candidates
• Evidence Level: High (Cochrane reviews, RCTs, guideline-based)
• Last Updated: 2026-01-16
• Topic Number: 671/1,071